Validation of a four-graded scale for severity of heartburn in patients with symptoms of gastroesophageal reflux disease

Value in Health

Volumn 11, Issue 4, 2008, Pages 765-770

  Junghard, Ola ^a   Wiklund, Ingela ^a,b  

^a ASTRAZENECA R AND D   (Sweden)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Four graded scale; Gastroesophageal reflux disease; Heartburn; Validation

Indexed keywords

ESOMEPRAZOLE; OMEPRAZOLE;

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; CONSTRUCT VALIDITY; CORRELATION ANALYSIS; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RATING SCALE; RELIABILITY; RESPONSIVENESS; SYMPTOMATOLOGY; TREATMENT RESPONSE; VALIDATION STUDY;

EID: 47749139395     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2007.00313.x     Document Type: Article

References (17)

1. Tytgat GN. Review article: management of mild and severe gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003 17 (Suppl. 2 S52 6.
2. Bytzer P. Assessment of reflux symptom severity: methodological options and their attributes. Gut 2004 53 (Suppl. 4 S28 34.
3. Kahrilas PJ, Falk GW, Johnson DA, et al. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. The Esomeprazole Study Investigators. Aliment Pharmacol Ther 2000 14 : 1249 58.
4. Venables TL, Newland RD, Patel AC, et al. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol 1997 32 : 965 73.
5. Katz PO, Castell DO, Levine D. Esomeprazole resolves chronic heartburn in patients without erosive oesophagitis. Aliment Pharmacol Ther 2003 18 : 875 82.
6. Armstrong D, Talley NJ, Lauritsen K, et al. The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther 2004 20 : 413 21.
7. Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 1998 7 : 75 83.
8. Fayers P, Machin D. Quality of Life: Assessment, Analysis and Interpretation. Chichester : Wiley, 2000.
9. Fleiss JL. Design and Analysis of Clinical Experiments. New York : Wiley, 1999.
10. Svedlund J, Sjodin I, Dotevall G. GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988 33 : 129 34.
11. Dimenas E, Glise H, Hallerback B, et al. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995 30 : 1046 52.
12. Junghard O, Carlsson R, Lind T. Sufficient control of heartburn in endoscopy-negative gastro-oesophageal reflux disease trials. Scand J Gastroenterol 2003 38 : 1197 9.
13. Wyrwich KW, Tardino VM. A blueprint for symptom scales and responses: measurement and reporting. Gut 2004 53 (Suppl. 4 S45 8.
14. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life. Med Care 2003 41 : 582 92.
15. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994 47 : 81 7.
16. McColl E. Best practice in symptom assessment: a review. Gut 2004 53 (Suppl. 4 S49 54.
17. McColl E, Junghard O, Wiklund I, et al. Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients. Am J Gastroenterol 2005 100 : 11 8.